Thyroid Hormones and Cardiometabolic Risk Factors in Saudi Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

被引:1
|
作者
Saeed, Walaa Mohammed [1 ,3 ]
Alsehli, Fahad [2 ]
机构
[1] Taibah Univ, Fac Appl Med Sci, Dept Med Lab Technol, Al Madinah Al Munawarah, Saudi Arabia
[2] King Salman Med City, Pathol, Madinah, Saudi Arabia
[3] Taibah Univ, Fac Appl Med Sci, Dept Med Lab Technol, 344,Postal Code 3000, Al Madinah Al Munawarah, Saudi Arabia
来源
关键词
thyroid disorder; insulin resistance; obesity; polycystic ovary syndrome; atherogenic index of plasma; INTIMA-MEDIA THICKNESS; SUBCLINICAL HYPOTHYROIDISM; CARDIOVASCULAR-DISEASE; DYSFUNCTION; METAANALYSIS; CONSENSUS; SOCIETY; EVENTS;
D O I
10.2147/IJWH.S405942
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The PCOS-thyroid nexus has recently drawn the focus of various investigations due to the prevalence of thyroid problems in PCOS. Additionally, risk factors for cardiovascular disease (CVD) are more prevalent in PCOS women. Therefore, we aim to assess the levels of thyroid hormones in Saudi females with polycystic ovary syndrome (PCOS) and to examine the correlation between cardiometabolic risk factors (CMRFs) and thyroid hormones in PCOS patients.Methods: A cross-sectional research with 200 PCOS-diagnosed female patients was conducted from April 2018 to April 2020. In addition to other anthropometric and serum biochemical markers, glycemic status, thyroid function test, lipid profiles, homocysteine, and C-reactive protein levels were detected in patients.Results: In PCOS, hypothyroidism is more common than hyperthyroidism (55 vs 27.5%, p = 0.05). While women with raised TSH (hypothyroidism) had a higher BMI, WC, FBG, and poorer HDL-C (p< 0.05). Significant differences were found in LDL-C, TG, Homocysteine, and CRP levels (all p<0.001 and< 0.05). PCOS women with hypothyroidism at increased risk of CVD, as indicated by AIP (Atherogenic Index of plasma) (0.57 & PLUSMN;0.42) was found. The elevated TSH levels were favorably linked with TG, Homocysteine, CRP, BMI, AIP, and WC (all p< 0.001, 0.05) but negatively connected with HDL-C and FT4.Conclusion: A strong relationship between PCOS and thyroid dysfunction was detected since PCOS hypothyroid groups had higher TSH levels and CMRFs. This group's CVD risk was elevated due to CRP, homocysteine, triglycerides, and obesity.
引用
收藏
页码:1197 / 1203
页数:7
相关论文
共 50 条
  • [41] Sexual Function in Women with Polycystic Ovary Syndrome Living in Stable Heterosexual Relationships: A Cross-Sectional Study
    Warchala, Anna
    Madej, Pawel
    Kochanowicz, Marta
    Krzystanek, Marek
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [42] Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study
    Bedaiwy, Mohamed A.
    Abdel-Rahman, Mohamed Y.
    Tan, Justin
    AbdelHafez, Faten F.
    Abdelkareem, Amr O.
    Henry, Drisana
    Lisonkova, Sarka
    Hurd, William W.
    Liu, James H.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (05) : 659 - 664
  • [43] Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: A cross-sectional study
    Kim, Jung-Hee
    Kim, Oksoo
    Jung, Heeja
    Pang, Yanghee
    Dan, Hyunju
    HEALTH CARE FOR WOMEN INTERNATIONAL, 2022, 43 (1-3) : 85 - 97
  • [44] Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study
    Marina Sourouni
    Julia Estermann
    Norman Bitterlich
    Susanna Weidlinger
    Annette Bachmann
    Petra Stute
    Archives of Gynecology and Obstetrics, 2024, 309 : 2115 - 2126
  • [45] The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome
    Krysiak, Robert
    Basiak, Marcin
    Szkrobka, Witold
    Okopien, Boguslaw
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1165 - 1173
  • [46] Cardiometabolic biomarkers in women with polycystic ovary syndrome
    van der Ham, Kim
    Louwers, Yvonne, V
    Laven, Joop S. E.
    FERTILITY AND STERILITY, 2022, 117 (05) : 887 - 896
  • [47] VISFATIN AS A POTENTIAL CARDIOMETABOLIC RISK FACTOR IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Koleva-Tyutyundzhieva, D.
    Ilieva-Gerova, M.
    Deneva, T.
    Nikolova, J.
    Orbetzova, M.
    ATHEROSCLEROSIS, 2023, 379 : S104 - S104
  • [48] Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations
    Deswal, Ritu
    Nanda, Smiti
    Ghalaut, Veena S.
    Roy, Prasanta S.
    Dang, Amita S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 370 - 379
  • [49] Correlation of Vitamin D Levels with Polycystic Ovary Syndrome: A Cross-sectional Study
    Jauhari, Reenoo
    Mathur, Prashant
    Gupta, Vineeta
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (59B) : 41 - 47
  • [50] Environmental exposure to triclosan and polycystic ovary syndrome: a cross-sectional study in China
    Ye, Jiangfeng
    Zhu, Wenting
    Liu, Han
    Mao, Yuchan
    Jin, Fan
    Zhang, Jun
    BMJ OPEN, 2018, 8 (10):